SCHEMBL21603874

SCHEMBL21603874

CC1CCCc2c1sc(NC(=O)C1CC1)c2C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
HSD17B10 Q99714 2/20 0.50
MAPT P10636 2/20 0.50
FLT3 P36888 1/20 0.49
ALDH1A1 P00352 3/20 0.41
GAA P10253 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ABCC1 P33527 3/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
PTPN1 P18031 3/20 0.41
PTPRC P08575 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPRB P23467 1/20 0.41
PTPRE P23469 1/20 0.41
PTPN6 P29350 1/20 0.41
CNR2 P34972 2/20 0.41
CNR1 P21554 1/20 0.41
CXCR2 P25025 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL21597714 0.96 KDM4E (0.47) KDM4EHSD17B10MAPTFLT3ALDH1A1
SCHEMBL21597081 0.87 MAPT (0.48) KDM4EHSD17B10MAPTFLT3ALDH1A1
SCHEMBL21603868 0.83 MAPT (0.58) KDM4EHSD17B10MAPTALDH1A1GAA
SCHEMBL21597282 0.82 CNR2 (0.47) KDM4EHSD17B10MAPTFLT3ALDH1A1
SCHEMBL21597687 0.81 MAPT (0.41) KDM4EHSD17B10MAPTFLT3ALDH1A1
SCHEMBL21603891 0.79 ABCC1 (0.64) KDM4EHSD17B10MAPTFLT3ALDH1A1
SCHEMBL21597670 0.79 MAPT (0.47) KDM4EHSD17B10MAPTFLT3ALDH1A1
SCHEMBL21597744 0.79 MAPT (0.53) KDM4EHSD17B10MAPTALDH1A1GAA
SCHEMBL3914277 0.78 FLT3 (0.77) KDM4EHSD17B10MAPTFLT3ALDH1A1
Water SCHEMBL21597829 0.76 ABCC1 (0.60) KDM4EHSD17B10MAPTFLT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018021-B2 Thiophene derivatives for the treatment of disorders caused by IgE UCB Biopharma SRL (BE) 2024-06-25 US disclosed
WO-2019243550-A1 THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE UCB Biopharma SRL (BE) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018021-B2 Thiophene derivatives for the treatment of disorders caused by IgE TSLP, CYSLTR1, CYSLTR2 KDM4E 3965/4885HSD17B10 1200/4885MAPT 2356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.